SK 216
Modify Date: 2024-01-05 17:35:58
SK 216 structure
|
Common Name | SK 216 | ||
|---|---|---|---|---|
| CAS Number | 654080-03-2 | Molecular Weight | 533.523 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H29NO6Na2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SK 216SK 216 is a potent, selective inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 44 uM; reduces the size of subcutaneous tumors and the extent of metastases in mice tumor model, also reduces the extent of angiogenesis in the tumors and inhibits VEGF-induced migration and tube formation by human umbilical vein endothelial cells in vitro. |
| Name | Disodium [5-({6-[5-(2-methyl-2-propanyl)-1,3-benzoxazol-2-yl]-2-naphthyl}oxy)pentyl]malonate |
|---|---|
| Synonym | More Synonyms |
| Description | SK 216 is a potent, selective inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 44 uM; reduces the size of subcutaneous tumors and the extent of metastases in mice tumor model, also reduces the extent of angiogenesis in the tumors and inhibits VEGF-induced migration and tube formation by human umbilical vein endothelial cells in vitro. |
|---|---|
| References | References 1. Masuda T, et al. Mol Cancer Ther. 2013 Nov;12(11):2378-88. 2. Mutoh M, et al. Carcinogenesis. 2008 Apr;29(4):824-9. 3. Takayama Y, et al. Cancer Res. 2016 Jun 1;76(11):3285-94. View Related Products by Target Plasminogen Activator Inhibitor-1 (PAI-1) |
| Molecular Formula | C29H29NO6Na2 |
|---|---|
| Molecular Weight | 533.523 |
| Exact Mass | 533.179016 |
| Propanedioic acid, 2-[5-[[6-[5-(1,1-dimethylethyl)-2-benzoxazolyl]-2-naphthalenyl]oxy]pentyl]-, sodium salt (1:2) |
| Disodium [5-({6-[5-(2-methyl-2-propanyl)-1,3-benzoxazol-2-yl]-2-naphthyl}oxy)pentyl]malonate |